BriaCell Therapeutics Corp.’s Post

President & CEO, Dr. William V. Williams, comments on BriaCell's ongoing commitment to finding therapeutic options for difficult-to-treat #metastaticbreastcancer patients. Read more: https://bit.ly/3Ze4xCO #SABCS24 #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

Dr. William V. Williams, BriaCell’s President & CEO, offers insight into the recently reported positive survival data, outperforming patients, and survival rates in BriaCell's Phase 2 #metastaticbreastcancer study. Learn more: https://bit.ly/4fb75rw #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments

Five BriaCell posters (four today and one on Dec 13th) showcase robust survival and clinical benefit data, plus key biomarker data from Phase 2 trial of Bria-IMT™ in #metastaticbreastcancer (#MBC). https://bit.ly/4fbDRIO #SABCS24 #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

Median overall survival of 15.6 months is reported in BriaCell’s most recent Phase 2 Bria-IMT™ study patients (treated since 2022) vs. 6.7-9.3 months for similar patients reported in the literature. Please see the table below and visit our site for more information. https://bit.ly/3MHZDrQ #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments

Giuseppe Del Priore, MD, MPH, BriaCell’s CMO, provides insights on the company's positive overall survival data of Phase 2 Bria-IMT™ study in #metastaticbreastcancer. https://bit.ly/3MHZDrQ #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments

Dr. William V. Williams, BriaCell’s President & CEO, shares insight on the Company's positive feedback received from its Pre-IND meeting with the FDA for Bria-PROS+™ in #prostatecancer. Learn more: https://bit.ly/3TmeEDc #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer #lungcancer #melanoma #noveldrugs #MBC

BriaCell President and CEO, Dr. William V. Williams, highlights the positive overall survival benefit in late stage #metastaticbreastcancer patients being treated with BriaCell’s Bria-IMT™ combination regimen. Learn more: https://bit.ly/3MHZDrQ #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments

This month, help us raise awareness for #BreastCancerAwarenessMonth. Awarded a patent by the USPTO, BriaCell is developing Bria-OTS™, a novel personalized “off-the-shelf” #immunotherapy for the treatment of metastatic #breastcancer. Learn more about this innovative platform: https://bit.ly/3TF7Jn0 #breastcancerawareness #BCAM #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #personalizedcancerimmunotherapies #personalizedcancerdrugs #breastcancer #noveldrugs #MBC

BriaCell's upcoming #SABCS24 presentations include planned Phase 3 study design expanding use of Bria-IMT™ + CPI to any cancer patient with central nervous system (CNS) metastases. https://bit.ly/3NRgOaH #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

BriaCell’s Chief Medical Officer, Dr. Giuseppe Del Priore, addresses the significance of the first patient dosed with Bria-OTS™, marking a major milestone for the company and cancer patients alike. Read more: https://bit.ly/3V1asJY #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments